Ben Auspitz

Director at Antlia Bioscience.

Encinitas, CA
Antlia Bioscience

Raised on Antlia Bioscience filings

$6M

of $20M offered across 1 Form D filing

Form D filings: 1
Teammates: 5
Last filing: Jun 5, 2026

Company

Antlia Bioscience

Biotech · Encinitas, CA

Long-acting peptide therapy for chronic heart failure

Long-acting peptide therapy for chronic heart failure

Investors: 3
Still open: $14M

Investors: 3
Sector: Biotech
HQ: Encinitas, CA

Antlia Bioscience filings

Antlia Bioscience Form D filings
Filed	Security	Sold of offered	Filing
Jun 5, 2026	Equity	$6M/ $20M	Form D

EquityFiled Jun 5, 2026Form D
$6M/ $20M

Works with

Also named on Antlia Bioscience filings

Ankit MahadeviaChief Executive Officer, Form D signerForm D signer Martin TaylorDirector Brian Laurence JohnsonExecutive Officer, Director Carlos Garcia EcheverriaDirector Nihal SinhaDirector